[HTML][HTML] Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
JL Bell, K Wächter, B Mühleck, N Pazaitis… - Cellular and molecular …, 2013 - Springer
The insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1, IGF2BP2,
IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies …
IGF2BP3) belong to a conserved family of RNA-binding, oncofetal proteins. Several studies …
[HTML][HTML] Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma
YL Chen, YM Jeng, HC Hsu, HS Lai, PH Lee… - International Journal of …, 2013 - Elsevier
INTRODUCTION: Insulin-like growth factor-II mRNA-binding protein 3 (IMP3), a newly
identified oncofetal RNA-binding protein, plays a pivotal role in the regulation of cell growth …
identified oncofetal RNA-binding protein, plays a pivotal role in the regulation of cell growth …
Expression of insulin‐like growth factor II mRNA‐binding protein 3 in squamous cell carcinomas of the head and neck
TS Clauditz, CJ Wang, A Gontarewicz… - Journal of oral …, 2013 - Wiley Online Library
J Oral Pathol Med (2013) 42: 125–132 Background: Insulin‐like growth factor II mRNA‐
binding protein 3 (IMP3) was found overexpressed in various cancer types suggesting its …
binding protein 3 (IMP3) was found overexpressed in various cancer types suggesting its …
[HTML][HTML] IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study
S Soddu, E Di Felice, S Cabras… - European journal of …, 2013 - ncbi.nlm.nih.gov
The protein insulin-like growth factor II mRNA binding protein 3 (IMP-3) is an important factor
for cell migration and adhesion in malignancies. Recent studies have shown a remarkable …
for cell migration and adhesion in malignancies. Recent studies have shown a remarkable …
Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma
K Chen, KM Cornejo, W Ye, Q Wu, J Liang, Z Jiang - Human Pathology, 2013 - Elsevier
An accurate diagnosis of laryngeal squamous cell carcinoma (LSCC) is essential for patient
management. The diagnosis of LSCC, especially in superficial biopsies, can present a …
management. The diagnosis of LSCC, especially in superficial biopsies, can present a …
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
H Tahara, T Tsunoda, Y Nakamura, Y Daigo… - US Patent …, 2013 - Google Patents
EP 1854.473 A1 1, 2007 JP 2000-5100O2 A 8, 2000 JP 2005-523688 A 8, 2005 JP 2005-
230011 A 9, 2005 JP 2005-525789 A 9, 2005 JP 2005-531280 A 10/2005 JP 2006-500949 …
230011 A 9, 2005 JP 2005-525789 A 9, 2005 JP 2005-531280 A 10/2005 JP 2006-500949 …
Use of IMP3 as a prognostic marker for cancer
Z Jiang - US Patent 8,383,089, 2013 - Google Patents
Provided herein are methods and compositions for the prognostic evaluation of a patient
suspected of having, or having, cancer by assessing the expression of IMP3 in a biological …
suspected of having, or having, cancer by assessing the expression of IMP3 in a biological …
The Prognostic Significance of Insulin-like Growth Factor II mRNA-Binding Protein 3 (IMP3) Expression in Oral Epithelial Dysplasia: a Retrospective Case-Control …
GN Mainville - 2013 - rave.ohiolink.edu
Oral epithelial dysplasia (OED) is a potentially precancerous lesion with an estimated rate of
malignant transformation ranging from< 1% to 17.5%. Although risk of progression to oral …
malignant transformation ranging from< 1% to 17.5%. Although risk of progression to oral …